Trials / Completed
CompletedNCT03710590
Effects of Electronic Cigarette Settings and Liquid Concentrations in Cigarette Smokers and Electronic Cigarette Users
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Virginia Commonwealth University · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research study is to find out how different types of electronic cigarettes (ECIG) settings, combined with e-liquids of differing nicotine concentrations, affect blood nicotine levels, use behavior (how users puff), and how users feel.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | ECIG Lab Session 15 watts, 10 mg nicotine | During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout. |
| OTHER | ECIG Lab Session 15 watts, 15 mg nicotine | During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout.). |
| OTHER | ECIG Lab Session 15 watts, 30 mg nicotine | During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout. |
| OTHER | ECIG Lab Session 30 watts, 10 mg nicotine | During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout. |
| OTHER | ECIG Lab Session 30 watts, 15 mg nicotine | During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout. |
| OTHER | ECIG Lab Session 30 watts, 30 mg nicotine | During each session, participants will first complete a 10-puff product use bout, and then a 90-minute ad lib product use bout. |
Timeline
- Start date
- 2019-01-15
- Primary completion
- 2020-03-09
- Completion
- 2020-03-09
- First posted
- 2018-10-18
- Last updated
- 2022-10-06
- Results posted
- 2021-05-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03710590. Inclusion in this directory is not an endorsement.